Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

NCT00981903 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

131

Enrollment

OTHER

Sponsor class

Stopped Tinzaparin will no longer be available in the United States

Conditions

Venous Thromboembolism
Cancer

Interventions

DRUG: Tinzaparin sodium

Sponsor

University of Southern California

Collaborators

[object Object]